ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.

Sarah Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.